[HTML][HTML] ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer
W Allum, F Lordick, M Alsina, E Andritsch… - Critical reviews in …, 2018 - Elsevier
Background ECCO essential requirements for quality cancer care (ERQCC) are checklists
and explanations of organisation and actions that are necessary to give high-quality care to …
and explanations of organisation and actions that are necessary to give high-quality care to …
Metabolic tumor volume change predicts long-term survival and histological response to preoperative chemotherapy in locally advanced esophageal cancer
T Makino, M Yamasaki, K Tanaka, Y Masuike… - Annals of …, 2019 - journals.lww.com
Objective: Here, we assess the ability of metabolic tumor volume (MTV) as measured by 18
F-fluorodeoxyglucose-positron emission tomography/computed tomography (18 F-FDG …
F-fluorodeoxyglucose-positron emission tomography/computed tomography (18 F-FDG …
Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes
Background The efficacy of neoadjuvant chemotherapy (NACT) correlates with patient
survival in oesophageal squamous cell carcinoma (OSCC), but optimal evaluation of the …
survival in oesophageal squamous cell carcinoma (OSCC), but optimal evaluation of the …
Usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant …
T Yokose, M Kitago, Y Matsusaka, Y Masugi… - Cancer …, 2020 - Wiley Online Library
Abstract Background The Response Evaluation Criteria in Solid Tumors (RECIST) for
computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However …
computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However …
Meta-analysis of prognostic factors of overall survival in patients undergoing oesophagectomy for oesophageal cancer
SK Kamarajah, EJ Marson, D Zhou… - Diseases of the …, 2020 - academic.oup.com
ABSTRACT Introduction Currently, the American Joint Commission on Cancer (AJCC)
staging system is used for prognostication for oesophageal cancer. However, several …
staging system is used for prognostication for oesophageal cancer. However, several …
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT–RECIST 1.1 vs. PERCIST 1.0
S Odawara, K Kitajima, T Katsuura, Y Kurahashi… - European journal of …, 2018 - Elsevier
Purpose We compared the response classification systems Response Evaluation Criteria in
Solid Tumors (RECIST) 1.1 and Positron Emission Tomography Response Criteria in Solid …
Solid Tumors (RECIST) 1.1 and Positron Emission Tomography Response Criteria in Solid …
[HTML][HTML] Phase II study of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancer
M Kim, B Keam, TM Kim, HG Kim… - … : Official Journal of …, 2017 - synapse.koreamed.org
Purpose The objective of this multicenter phase II study was to evaluate the efficacy and
safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable …
safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable …
Restaging oesophageal cancer after neoadjuvant therapy with 18F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery
JM Findlay, RS Gillies, JM Franklin, EJ Teoh… - European …, 2016 - Springer
Objectives It is unknown whether restaging oesophageal cancer after neoadjuvant therapy
with positron emission tomography-computed tomography (PET-CT) is more sensitive than …
with positron emission tomography-computed tomography (PET-CT) is more sensitive than …
Prognostic value of standardized uptake ratio in patients with trimodality treatment of locally advanced esophageal carcinoma
R Bütof, F Hofheinz, K Zöphel… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The prognosis of patients with esophageal carcinoma remains dismal despite ongoing
efforts to improve treatment options. For locally advanced tumors, several randomized trials …
efforts to improve treatment options. For locally advanced tumors, several randomized trials …
Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter …
Y Taniyama, K Murakami, N Yoshida, K Takahashi… - BMC cancer, 2021 - Springer
Background Evaluating the effect on primary lesions is important in determining treatment
strategies for esophageal cancer. The Response Evaluation Criteria in Solid Tumors system …
strategies for esophageal cancer. The Response Evaluation Criteria in Solid Tumors system …